What is the difference between neoadjuvant and adjuvant chemotherapy?

Neoadjuvant chemotherapy comes before surgery or radiation therapy. Adjuvant chemotherapy comes after. The drugs can be the very same ones. Only the timing differs, and the timing changes what the treatment is trying to do.

• Neoadjuvant chemotherapy is given before surgery or radiation therapy to make a tumor smaller.
• Adjuvant chemotherapy is given after surgery or radiation therapy to destroy cancer cells that may remain.

Adjuvant chemo treats a problem no one can see. Surgery takes out the tumor a surgeon can find. But single cancer cells may have already slipped into the blood or lymph fluid. These stray cells are called micrometastases. No scan can pick them up. Chemotherapy travels through the bloodstream and reaches them. That is why adjuvant chemo is offered even when the surgeon says all visible cancer is gone.

Neoadjuvant chemo does three separate jobs. It shrinks the tumor, which can make a smaller operation possible. It starts drug treatment weeks earlier, with no wait for a surgical wound to heal. And it turns the tumor into a live test of whether the drugs work on your cancer. Nobody can know that in advance.

That third job is worth understanding. Sometimes the tissue removed at surgery shows no cancer left at all. That result is called a pathologic complete response. It is a strong sign the drugs did their work. One lung cancer trial added the immunotherapy drug nivolumab to chemo before surgery. In that group, 24% of surgical samples showed no cancer. With chemo alone, only 2% did. If instead a tumor barely changes, or grows, the team learns that early. They can switch drugs or move up the surgery date.

In breast cancer, shrinking the tumor first can let a surgeon remove a lump rather than the whole breast. It can also shrink cancer in the underarm lymph nodes. Then fewer nodes need to come out, which lowers the risk of lasting arm swelling.

Neoadjuvant treatment creates one wrinkle that confuses many people. After chemo, the tumor measured under the microscope is smaller than the tumor you had at diagnosis. Cancer registries handle this by recording the size from before treatment started. They do not use the shrunken size found at surgery. So your pathology report may list a small tumor while your stage still reflects the larger one. That is not an error. Doctors mark a stage assigned after neoadjuvant treatment with a lowercase letter y to flag exactly this.

Some people get both. A common pattern is chemo, then surgery, then more drug treatment if cancer was still present in the removed tissue.

Two questions are worth asking your oncologist. First, what is the goal here? Shrinking the tumor to allow a smaller operation and lowering the risk of return are different aims, and they lead to different choices. Second, how will you know it is working? For neoadjuvant chemo, the answer usually means an exam and a scan partway through. Ask what the plan is if the tumor does not respond.